Patents by Inventor Daisy Manish Shah

Daisy Manish Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS NADPH OXIDASE INHIBITORS
    Publication number: 20200247800
    Abstract: The present application relates to substituted fused heteroaryl and hetero-cyclic compounds, useful as nicotinamide adenine dinucleotide phosphate oxidase inhibitors (NADPH oxidase inhibitors), processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by NADPH oxidase.
    Type: Application
    Filed: May 4, 2018
    Publication date: August 6, 2020
    Inventors: Sukeerthi Kumar, Abraham Thomas, Sachin Sundarlal Chaudhari, Laxmikant Atmaram Gharat, Neelima Khairatkar-Joshi, Daisy Manish Shah, Indranil Mukhopadhyay
  • Treatment of respiratory disorders using ROR-gamma inhibitors
    Patent number: 9855229
    Abstract: The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Particularly, the present patent application relates to treatment of a respiratory disorder using a ROR? inhibitor, wherein the ROR? inhibitor is administered by an inhalation route to a subject in need thereof.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: January 2, 2018
    Assignee: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Daisy Manish Shah, Vikram Mansingh Bhosale, Bhavik Jaysukhlal Lodhiya, Alamelu Mangai Thiraviam, Megha Marathe, Avinash Annaso Hadambar
  • Bicyclic heteroaryl indole analogues useful as ROR gamma modulators
    Patent number: 9682977
    Abstract: The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X, X1, M, R2, R3, R4, R5, m, n, and p are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (ROR?t). These compounds prevent, inhibit, or suppress the action of ROR?t and are therefore useful in the treatment of ROR?t mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases and cancer.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: June 20, 2017
    Assignee: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Sanjib Das, Sachin Sundarlal Chaudhari, Abraham Thomas, Shailesh Ramesh Pardeshi, Vishal Govindrao Deshmukh, Prashant Dilip Wadekar, Neelima Khairatkar-Joshi, Daisy Manish Shah, Malini Bajpai
  • TREATMENT OF RESPIRATORY DISORDERS USING ROR-GAMMA INHIBITORS
    Publication number: 20160346234
    Abstract: The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Particularly, the present patent application relates to treatment of a respiratory disorder using a ROR? inhibitor, wherein the ROR? inhibitor is administered by an inhalation route to a subject in need thereof.
    Type: Application
    Filed: May 31, 2016
    Publication date: December 1, 2016
    Inventors: Neelima KHAIRATKAR-JOSHI, Abhay KULKARNI, Daisy Manish SHAH, Vikram Mansingh BHOSALE, Bhavik Jaysukhlal LODHIYA, Alamelu Mangai THIRAVIAM, Megha MARATHE, Avinash Annaso HADAMBAR
  • BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS
    Publication number: 20160326163
    Abstract: The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X, X1, M, R2, R3, R4, R5, m, n, and p are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (ROR?t). These compounds prevent, inhibit, or suppress the action of ROR?t and are therefore useful in the treatment of ROR?t mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases and cancer.
    Type: Application
    Filed: December 9, 2014
    Publication date: November 10, 2016
    Inventors: Sanjib DAS, Sachin Sundarlal CHAUDHARI, Abraham THOMAS, Shailesh Ramesh PARDESHI, Vishal Govindrao DESHMUKH, Prashant Dilip WADEKAR, Neelima KHAIRATKAR-JOSHI, Daisy Manish SHAH, Malini BAJPAI
  • Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
    Patent number: 7538128
    Abstract: The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R1, and R2 are as defined herein.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: May 26, 2009
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, Gopalan Balasubramanian, V. S. Prasadarao Lingam, Daisy Manish Shah
  • Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
    Patent number: 7524844
    Abstract: The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R1, and R2 are as defined herein.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: April 28, 2009
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, Balasubramanian Gopalan, V.S. Prasada Rao Lingam, Daisy Manish Shah
  • ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS
    Publication number: 20080182851
    Abstract: The present invention provides Stearoyl CoA Desaturase (SCD) inhibitors. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase 1 (SCD1) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase (SCD) inhibitors.
    Type: Application
    Filed: November 19, 2007
    Publication date: July 31, 2008
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, V.S. Prasada Rao Lingam, Shantaram Kashinath Phatangare, Neelima Khairatkar-Joshi, Daisy Manish Shah, Deepak Vitthal Ukirde, Dattaguru Anandrao More
  • Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
    Patent number: 7230002
    Abstract: The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors their analogs, isomers, pharmaceutical compositions, therapeutic uses and methods of making the same.
    Type: Grant
    Filed: February 2, 2005
    Date of Patent: June 12, 2007
    Assignee: Glenmark Pharmaceuticals Ltd.
    Inventors: Abraham Thomas, Balasubramanian Gopalan, V. S. Prasada Rao Lingam, Daisy Manish Shah
  • Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation
    Patent number: 7205323
    Abstract: The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R1, and R2 are as defined herein.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: April 17, 2007
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, Gopalan Balasubramanian, V. S. Prasada Rao Lingam, Daisy Manish Shah